What is Sudden Hearing Loss?

Center For Hearing • July 15, 2021

For most people who experience hearing loss, the condition comes on gradually over a period of years. In rare cases, an abrupt loss of hearing occurs with little or no warning. This condition is known as sudden sensorineural hearing loss (SSHL).

What is Sudden Deafness?

Sudden deafness is defined as a hearing reduction of 30 dB or greater over three contiguous frequencies, occurring over a period of 72 hours or less. Ninety percent of cases result in unilateral (single-sided) hearing loss, which may be accompanied by dizziness or tinnitus.

The severity of the hearing loss varies. Some patients recover completely and without medical intervention in just a few days. Others find their symptoms improve gradually over a couple of weeks. Fifteen percent of those who experience sudden deafness will have hearing loss that worsens over time.

Who Develops Sudden Deafness?

Experts estimate that about one to six per every 5,000 people experience sudden deafness every year, although some suspect this number is much higher as the condition often goes undiagnosed.

People of all ages can develop sudden deafness. Most often, it affects adults in their late 40s and early 50s.

What Causes Sudden Deafness?

There are over 100 possible causes for SSHL. These include:

  • Infectious diseases
  • Head trauma
  • Abnormal tissue growth
  • Circulatory problems
  • Neurologic disorders
  • Toxic causes
  • Immunologic diseases
  • Inner ear problems such as Meniere’s disease
  • Ototoxic medications

Certain groups of antibiotics, in particular, have been shown to destroy the hair cells of the cochlea, causing sudden deafness that is often permanent in nature. These must be used with extreme caution and should be avoided unless they are the only viable course of treatment for a life-threatening illness. Be sure to question your physician or clinic thoroughly when antibiotics are prescribed.

Risk factors for SSHL include a prior diagnosis of meningitis, a recent head injury, ear infection, exposure to loud noise, a sudden change in pressure and starting a new medication.

What Are the Symptoms of Sudden Deafness?

Symptoms that often precede or accompany sudden deafness include:

  • Tinnitus (ringing in the ears)
  • Vertigo or dizziness
  • Fullness in the ear
  • A sudden loud “pop” in the ear, similar to what you’d experience with a change in pressure
  • Muffled hearing upon wakening or when trying to use the telephone

How is Sudden Deafness Diagnosed?

If you experience any of these symptoms, see a physician or audiologist immediately. Doctors believe that prompt medical attention offers the best chances for a full recovery. Do not delay – your hearing depends upon it.

Your doctor will first complete a physical exam, looking in your ear to determine if there is an obstruction. If there is no obvious cause to your sudden deafness, such as a buildup of fluid or earwax, your doctor will complete a pure tone hearing exam to test for sensorineural hearing loss.

A pure tone hearing test measures how loud different sounds must be before you can hear them. The results of this test are important, as a common sign of sudden deafness is a loss of 30 decibels and three connected frequencies within a 72 hour period. This change in hearing would make someone speaking at a normal volume sound like a whisper.

If you are diagnosed with sudden deafness, your doctor will order additional tests to determine the underlying cause. These may include a balance test, blood work and imaging.

How Is Sudden Deafness Treated?

Treatment varies and will depend upon the cause (if known). Steroids, which reduce inflammation and swelling and aid the body in fighting illness, are the most common treatment method for sudden deafness.

Additional treatments may include antibiotics to treat an infection or medication to suppress the immune system if the sudden deafness is caused by an autoimmune disorder.

For those with severe hearing loss that does not respond to treatment, your doctor may recommend the use of a hearing aid or cochlear implant.

Call Center For Hearing at (239) 434-0086 for more information or to schedule an appointment.


February 14, 2025
Hearing technology has come a long way over the years; however, one aspect of hearing loss that many hearing aids have difficulty addressing is trouble understanding speech in noise. Fortunately, some of today’s state-of-the-art devices can solve this problem utilizing deep neural networks (DNN) and artificial intelligence (AI). Sensorineural hearing loss causes difficulty understanding speech in background noise. This type of hearing loss is caused by damage to the hair cells of the inner ear that convert soundwaves into electrical energy, which are then interpreted by the brain. This causes the quality and quantity of the signal sent from the ears to the brain to diminish over time, resulting in the brain expending more energy and effort to make sense of it. DNNs may help improve the transmission of the neural code, making hearing easier on the brain. [1] It’s important to know what DNNs are to understand how they can help. DNNs are a subset of AI. They rapidly analyze large data sets so that they can teach hearing aids and other technological devices how to respond to data like a human would, all while verifying accuracy and making corrections. DNNs are beneficial in hearing technology because they can help with speech enhancement. DNNs can be applied as “time-frequency masks,” meaning select sounds—like speech—are allowed while other sounds are suppressed. DNNs can also identify and separate multiple voices, selecting a primary voice to emphasize and secondary voices to suppress. This feature can help hearing device wearers in a variety of settings. For example, at a restaurant or party, the hearing device can emphasize a conversation partner, allow other nearby voices at a reduced volume and suppress background noises such as dishes clinking. Schedule an appointment to talk to Center for Hearing about our vast state-of-the-art hearing solutions today— (239) 434-0086. [1] Published by Douglas L. Beck. (2021, January 15). Deep neural networks in hearing devices. Retrieved April 2, 2021 from https://www.hearingreview.com/hearing-products/hearing-aids/deep-neural-networks
February 14, 2025
A Boston biotech startup is attempting to develop the first gene therapy treatment for hearing loss. If successful, it promises to offer new hope to the estimated 300,000 Americans who suffer from gene-based hearing loss—a number that includes more than 4,000 newborns. The timing may not be ideal, but biotech companies have been largely immune from the effects of the COVID-19 pandemic and ensuing recession. Developing new drugs takes years, so these companies are better able to weather storms. And the efforts of biotechnology companies that are focusing on tools to prevent and treat potentially fatal health threats has resulted in soaring stock values for many of these companies, even in the face of the current crisis. Akouos, the Boston startup, was founded in 2016. Its goal is to develop the first gene therapy to treat hearing loss and is targeting a specific form of deafness that results from mutations in a single gene. They are experimenting with adeno-associated viruses, using them as vectors to deliver DNA that encodes a functioning gene in certain target cells. Around 7,000 people are afflicted with this type of genetic hearing loss. Adeno-associated viruses are considered viable candidates because they don’t usually cause disease and can be customized to treat a variety of genetic conditions. The company has partnered with two influential organizations: Massachusetts Eye and Ear and Lonza, a Swiss manufacturing company that holds contracts with various pharmaceutical makers. Manny Simons, Akouos’ co-founder and chief executive, holds a degree in neuroscience from Harvard College, a Ph.D. in biomedical engineering from the Massachusetts Institute of Technology, and an MBA from Harvard Business School. His desire to help those with hearing loss stems from his passion for playing the piano. “It’s easy to take hearing for granted,” said in a Boston Globe interview. “Maybe because music has been important to me, it’s something that I take a little less for granted.” [1] [1] Saltzman, J. (2020, June 22). Akouos, a startup developing a gene therapy for hearing loss, raises IPO value to $125 million - The Boston Globe. Retrieved June 30, 2020, from https://www.bostonglobe.com/2020/06/22/business/ipo-upped-akouos-boston-startup-working-gene-therapy-hearing-loss/
More Posts